Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRND | Q07001 | 6/20 | 0.59 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.59 |
| ▸ | CHRNG | P07510 | 2/20 | 0.59 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.59 |
| ▸ | NPY1R | P25929 | 1/20 | 0.58 |
| ▸ | NPY2R | P49146 | 1/20 | 0.58 |
| ▸ | NPY4R | P50391 | 1/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.58 |
| ▸ | GRIA1 | P42261 | 7/20 | 0.57 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.56 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.56 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.56 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.56 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.56 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.56 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19619302 | 0.90 | CHRND (0.56) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 | |
| SCHEMBL15788797 | 0.89 | CHRND (0.55) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 | |
| SCHEMBL31514303 | 0.84 | NAALAD2 (0.66) | CHRND | |
| SCHEMBL31514306 | 0.84 | NAALAD2 (0.66) | CHRND | |
| SCHEMBL12526095 | 0.84 | GRIA1 (0.56) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 | |
| SCHEMBL12527096 | 0.83 | CHRND (0.70) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 | |
| SCHEMBL14478103 | 0.83 | APC (0.60) | NPY1RNPY2RNPY4RNPY5RGRIA1 | |
| SCHEMBL25627390 | 0.80 | CHRND (0.50) | CHRNDCHRNA1CHRNGCHRNB1NPY1R | |
| SCHEMBL14765234 | 0.79 | CHRNB2 (0.64) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 | |
| SCHEMBL29467399 | 0.79 | CHRND (0.53) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140161723-A1 | IN VIVO METHODS OF MONITORING BIODISTRIBUTION | KODE BIOTECH LIMITED (NZ) | 2014-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140161723-A1 | IN VIVO METHODS OF MONITORING BIODISTRIBUTION | FABP1, FUCA1, LIPA | CHRND 2430/4885CHRNA1 3641/4885CHRNG 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.